Diagnosis and management of macular holes

International Ophthalmology Clinics

Volumn 39, Issue 4, 1999, Pages 175-189

  Pearlman, Joel ^a   Pieramici, Dante ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC VALUE; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA MACULA HOLE; REVIEW; SURGICAL TECHNIQUE; TREATMENT FAILURE; VITRECTOMY;

EID: 0032752126     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199903940-00012     Document Type: Review

References (58)

1. Noyes HD. Detatchment of the retina, with laceration of the macula lutea. Trans Am Ophthalmol Soc 1871;1:128-129
2. Lister W. Holes in the retina and their clinical significance. Br J Ophthalmol 1924;8:1-20
3. Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988;106:629-639
4. Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752-759
5. Johnson RN, Gass JD. Idiopathic macular holes. Observations, stages of formation, and implications for surgical intervention. Ophthalmology 1988;95:917-924
6. Madreperla SA, McCuen BW 2nd, Hickingbotham D, Green WR. Clinicopathologic correlation of surgically removed macular hole opercula. Am J Ophthalmol 1995; 120:197-207
7. Guyer DR, Green WR, de Bustros S, Fine SL. Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 1990;97:1045-1051
8. Frangieh GT, Green WR, Engel HM. A histopathologic study of macular cysts and holes. Retina 1981;1:311-336
9. Eye Disease Case Control Study Group. Risk factors for idiopathic macular holes. Am J Ophthalmol 1994;118:754-761
10. Chew EY, Sperduto RD, Hiller R, et al. Clinical course of macular holes: the Eye Disease Case-Control Study. Arch Ophthalmol 1999;117:242-246
11. Atmaca LS, Yilmaz M. Changes in the fundus caused by blunt ocular trauma. Ann Ophthalmol 1993;25:447-452
12. de Bustros S. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for Prevention of Macular Hole Study Group. Ophthalmology 1994;101:1055-1059
13. Martinez J, Smiddy WE, Kim J, Gass JD. Differentiating macular holes from macular pseudoholes. Am J Ophthalmol 1994;117:762-767
14. Gass JD. Age-dependent idiopathic macular foramen. Current concepts of the pathogenesis, diagnosis, and treatment. Ophthalmologe 1995;92:617-625
15. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254:178-181
16. Swanson EA, Izatt JA, Hee MR, et al. In vivo retinal imaging by optical coherence tomography. Opt Letter 1993;18:1864-1869
17. Beausencourt E, Elsner AE, Hartnett ME, Trempe CL. Quantitative analysis of macular holes with scanning laser tomography. Ophthalmology 1997;104:2018-2029
18. Byhr E, Lindblom B. Preoperative measurements of macular hole with scanning laser ophthalmoscopy. Correlation with functional outcome. Acta Ophthalmol Scand 1998; 76:579-583
19. Guez JE, Le Gargasson JF, Massin P, et al. Functional assessment of macular hole surgery by scanning laser ophthalmoscopy. Ophthalmology 1998;105:694-699
20. Le Gargasson JF, Rigaudiere F, Guez JE, et al. Contribution of scanning laser ophthalmoscopy to the functional investigation of subjects with macular holes. Doc Ophthalmol 1994;86:227-238
21. Asrani S, Zeimer R, Goldberg MF, Zou S. Serial optical sectioning of macular holes at different stages of development. Ophthalmology 1998;105:66-77
22. Asrani S, Zeimer R, Goldberg MF, Zou S. Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology 1997;104:1145-1151
23. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217-229
24. Hee MR, Puliafito CA, Wong C, et al. Optical coherence tomography of macular holes. Ophthalmology 1995;102:748-756
25. Schocket SS, Lakhanpal V, Miao XP, et al. Laser treatment of macular holes. Ophthalmology 1988;95:574-582
26. Bidwell AE, Jampol LM, Goldberg MF. Macular holes and excellent visual acuity. Case report. Arch Ophthalmol 1988;106:1350-1351
27. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991;109:654-659
28. Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671-1676
29. Freeman WR, Azen SP, Kim JW, et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Arch Ophthalmol 1997;115: 11-21
30. Fine SL. Macular hole: a continuing saga. Arch Ophthalmol 1999;117:248-249
31. Smiddy WE. Randomized trials and my practice: macular hole surgery. Presented at a meeting of the American Academy of Ophthalmology, Nov. 8-11, 1998, New Orleans, LA
32. Rice TA. Internal limiting membrane removal in surgery for full-thickness macular holes. In: Madreperla SA, McCuen BW, eds. Macular hole. Boston: Butterworth Heinemann; 1999:125-146
33. Poliner LS, Tornambe PE. Retinal pigment epitheliopathy after macular hole surgery. Ophthalmology 1992;99:1671-1677
34. Tornambe PE, Poliner LS, Grote K. Macular hole surgery without face-down positioning. A pilot study. Retina 1997;17:179-185
35. Goldbaum MH, McCuen BW, Hanneken AM, et al. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 1998;105:2140-2147
36. Garcia-Arumi J, Corcostegui B, Cavero L, Sararols L. The role of vitreoretinal surgery in the treatment of posttraumatic macular hole. Retina 1997;17:372-377
37. Yooh HS, Brooks HL Jr, Capone A Jr, et al. Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol 1996;122:67-75
38. Fekrat S, Wendel RT, de la Cruz Z, Green WR. Clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole. Retina 1995;15:53-57
39. Coleman DJ, Lucas BC, Fleischman JA, et al. A biologic tissue adhesive for vitreoretinal surgery. Retina 1988;8:250-256
40. Olsen TW, Aaberg Sr. TM, Sternberg P Jr, et al. The use of autologous fibrinogen and bovine thrombin to close full-thickness macular holes. Invest Ophthalmol Vis Sci 1996;37(suppl):S474
41. Olsen TW, Sternberg P, Martin DF, et al. Postoperative hypopyon after intravitreal bovine thrombin for macular hole surgery. Am J Ophthalmol 1996;121:575-577
42. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study. Retina 1993;13:296-301
43. Glaser BM, Michels RG, Kuppermann BD, et al. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology 1992;99:1162-1172
44. Glaser BM, Smiddy WE, Thompson JT, et al. Prospective randomized trial showing TGF-beta2 more effective than placebo in improving vision in eyes with macular holes. Ophthalmology 1993;100(suppl):73
45. Thompson JT, Smiddy WE, Williams GA, et al. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 1998;105:700-706
46. Liggett PE, Skolik DS, Horio B, et al. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology 1995;102:1071-1076
47. Ezra E, Wells JA, Charteris DG, et al. Macular hole surgery with and without autologous serum: a prospective study of 109 consecutive eyes. Invest Ophthalmol Vis Sci 1996; 37:S474
48. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995;233:549-554
49. Korobelnik JF, Hannouche D, Belayachi N, et al. Autologous platelet concentrate as an adjunct in macular hole healing: a pilot study. Ophthalmology 1996;103:590-594
50. Paques M, Chastang C, Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole. Ophthalmology 1999;106:932-938
51. Peyman GA, Daun M, Greve MD, et al. Surgical closure of macular hole using an absorbable macular plug. Int Ophthalmol 1997;21:87-91
52. Park SS, Marcus DM, Duker JS, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102:775-781
53. Banker AS, Freeman WR, Kim JW, et al. Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology 1997;104:1442-1452
54. Thompson JT, Sjaarda RN, Glaser BM, Murphy RP. Increased intraocular pressure after macular hole surgery. Am J Ophthalmol 1996;121:615-622
55. Paques M, Massin P, Santiago PY, et al. Visual field loss after vitrectomy for full-thickness macular holes. Am J Ophthalmol 1997;124:88-94
56. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995;119:48-54
57. Duker JS, Wendel R, Patel AC, Puliafito CA. Late re-opening of macular holes after initially successful treatment with vitreous surgery. Ophthalmology 1994;101:1373-1378
58. Smiddy WE, Sjaarda RN, Glaser BM, et al. Reoperation after failed macular hole surgery. Retina 1996;16:13-18